Skip to main content

Balaxi Pharmaceuticals Ltd

Stage 4 · Declining · week 13

Balaxi Pharmaceuticals Limited engages in the international wholesale distribution of pharmaceuticals, builders hardware, and FMCG products in India, Africa, and Latin America. More about the company

₹22.4
-1.28% today
₹124 Cr · Micro cap
Market Neutral — FadingHealth Care 45.7% in Stage 2-1.4 pts / 20dHealth Care Equipment & Supplies 30.0%-10.0 pts
Loading price chart…
vs 52W High
-50.1%
₹15.7 lo₹44.9 hi
50.1% below 52W high — deep Stage 4 damage
In Stage 4, distance from the 52W high reflects ongoing decline — not a discount. Avoid catching falling knives.
Stage Maturity
Week 13
1w13w26w
Week 13 — established downtrend
How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure — there's no 'bottom' time to buy.
vs 200 DMA
-5.9%
200 DMA: ₹23.8 · sloping down
In Stage 4, the stock is below its 200 DMA — the hallmark of a downtrend. No long positions warranted until this reverses structurally.
Rel Volume
0.37x
vs 50-day avg
High volume on down days in Stage 4 confirms institutional selling. Low volume bounces are typical — they lack real buyers and should not be mistaken for reversals.
Trend Health
↓
MA20 rolling over · -1.9% vs MA50 -1.7%
Two-layer momentum read: the glyph shows whether the 20-day MA is rising (↑/↗), flat (→), or rolling over (↓). The ⇈ flag fires when the 20-day MA is pulling away from the 50-day MA — short-term momentum building on top of the longer trend. Best when both glyphs agree.
1M
-11.8%
3M
-6.8%
6M
+4.2%
YTD
-20.1%
1Y
-48.1%
Sector
Health Care
↓ Peaking
Stage 2%
45.7%
20d Δ
-1.4pp
1M return
-1.8%
3M return
+4.4%
Sector Stage-2 % · last 20 days
Sector has 77 Stage 2 leaders. See Health Care Stage 2 →
Industry
Health Care Equipment & Supplies
↓ Peaking
Stage 2%
30.0%
20d Δ
-10.0pp
1M return
+6.2%
3M return
-3.1%
Industry Stage-2 % · last 20 days
Industry has 3 Stage 2 leaders. See Health Care Equipment & Supplies Stage 2 →
Stage Cycle Timeline2023-07-11 → 2026-10-07
S4 27w
S2 21w
S4 81w
2023-07-112026-10-07
S1S2S3S4Setup score (0–10, dashed line at 5)
S4 27w → S1 5w → S2 21w → S3 11w → S4 81w → S1 10w → S4 12w current
Total tracked: 169 weeks across 7 stage runs.
Scan Membership
Breakout Watch
Latest: 2024-02-26
Stocks that stay in the scan for 13+ weeks are in the highest observed-return cohort — they keep qualifying because the structure remains intact, not by luck. Persistence in the scan is itself a quality signal.
Recent Stage Timeline
2026-10-07S4
Wk 13 · Vol 0.37x
2026-10-06S4
Wk 12 · Vol 0.20x
2026-10-05S4
Wk 12 · Vol 0.55x
2026-10-01S4
Wk 12 · Vol 0.50x
2026-09-30S4
Wk 12 · Vol 0.29x
2026-09-29S4
Wk 12 · Vol 0.44x
2026-09-28S4
Wk 11 · Vol 1.16x
2026-09-25S4
Wk 11 · Vol 0.27x
2026-09-24S4
Wk 11 · Vol 0.49x
2026-09-23S4
Wk 11 · Vol 2.00x
2026-09-22S4
Wk 11 · Vol 0.56x
2026-09-21S4
Wk 10 · Vol 0.17x
Sector Peers — Stage 2All →
KOPRAN
wk 19 · -5.0% from hi
9.0
SMSPHARMA
wk 3 · -3.0% from hi
8.7
KILITCH
wk 2 · -1.7% from hi
8.7
BAFNAPH
wk 17 · 0.0% from hi
8.6
ZIMLAB
wk 21 · 0.0% from hi
8.3
Moving averages & range
50 DMA
₹23.5
200 DMA
₹23.8
52W High
₹44.9
52W Low
₹15.7
5D Low
₹22.3
Resistance levels (recent highs)
20d High
₹23.7
60d High
₹25.8
120d High
₹29.1
250d High
₹44.9
Next resistance
+5.8%
to 20d High
P/E (TTM)
14.6
Forward —
Earnings Growth (YoY)
-93.8%
Revenue -1.0%
About this companyHealth Care· Health Care Equipment & Supplies

Balaxi Pharmaceuticals Limited engages in the international wholesale distribution of pharmaceuticals, builders hardware, and FMCG products in India, Africa, and Latin America. The company offers pharmaceutical products across various therapeutic areas, including antibiotics, analgesic, anti-malaria, and others. It also provides biscuits and toothpaste. The company was formerly known as Balaxi Ventures Limited and changed its name to Balaxi Pharmaceuticals Limited in October 2020. The company was incorporated in 1942 and is headquartered in Hyderabad, India. Balaxi Pharmaceuticals Limited is a subsidiary of Balaxi Overseas Private Limited.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-07. Past data patterns are not indicative of future results. This page is a data analytics tool only.